The US Food and Drug Administration is extending a public-private partnership it has already undertaken to assess COVID-19 therapies to also evaluate tests for the SARS-CoV-2 virus. The announcement comes after the agency pulled a number of serology tests from shelves after serious concerns about their effectiveness.
The agency said it has joined the Reagan-Udall Foundation for the Food and Drug Administration, and the Friends of Cancer...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?